Innoprot is a biotechnology company provider of Cell-Based Assays for drug discovery & development applications. Innoprot offers a wide range of stable cell lines and primary cells fully validated for High- Troughput Screening and High Content Screening. Stable cell lines developed by Innoprot are focused on drug discovery targeting mainly GPCRs, Nuclear hormone receptors, enzymes implicated in neurodegenerative diseases and ion channels. Innoprot has a proprietary technology for High Content Screening, which allow monitor changes in the concentrations of intracellular cAMP or Calcium by fluorescence imaging. Innoprot also offers custom assay development and High Content Screening Services, providing solutions to speed up the drug discovery campaigns of the customers.